ArticleCancer immunology, immunotherapy : CII2010

The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells.

Evelien L J M Smits et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.